scholarly journals Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab vs. Chemotherapy as First-Line Therapy in Advanced Non-Small Cell Lung Cancer

2020 ◽  
Vol 10 ◽  
Author(s):  
Huabin Hu ◽  
Longjiang She ◽  
Mengting Liao ◽  
Yin Shi ◽  
Linli Yao ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Cost Effectiveness ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
First Line ◽  
First Line Therapy ◽  
Effectiveness Analysis ◽  
Line Therapy

Cost-effectiveness of pembrolizumab as first-line therapy for advanced non-small cell lung cancer

Lung Cancer ◽  
2018 ◽  
Vol 124 ◽  
pp. 248-254 ◽  
Author(s):  
Mina Georgieva ◽  
Joao P. da Silveira Nogueira Lima ◽  
Pedro Aguiar ◽  
Gilberto de Lima Lopes ◽  
Benjamin Haaland
Keyword(s):  
Lung Cancer ◽  
Cost Effectiveness ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy

scholarly journals Cost-Effectiveness of Pemetrexed Plus Cisplatin as First-Line Therapy for Advanced Nonsquamous Non-small Cell Lung Cancer

2009 ◽  
Vol 4 (11) ◽  
pp. 1404-1414 ◽  
Author(s):  
Robert Klein ◽  
Catherine Muehlenbein ◽  
Astra M. Liepa ◽  
Steve Babineaux ◽  
Ron Wielage ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Cost Effectiveness ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy

scholarly journals Cytotoxic Chemotherapy as First-Line Therapy for Advanced Non-Small-Cell Lung Cancer in Taiwan: Daily Practice

2016 ◽  
Vol 7 (11) ◽  
pp. 1515-1523 ◽  
Author(s):  
Yi-Hsin Liang ◽  
Yu-Yun Shao ◽  
Bin-Chi Liao ◽  
Ho-Sheng Lee ◽  
James Chih-Hsin Yang ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Daily Practice ◽  
Cytotoxic Chemotherapy ◽  
Small Cell ◽  
Small Cell Lung ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy
Sign in / Sign up

Export Citation Format

Share Document